Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 602

Test Your Knowledge #602: A 70-year-old man who has type 2 diabetes, coronary artery disease, and COPD...

A 70-year-old man who has type 2 diabetes, coronary artery disease, and chronic obstructive pulmonary disease is seen for an annual physical examination.

Advertisement

He notes no health-related concerns and has no acute symptoms. He is eating healthy foods but is unable to perform regular physical activity. His blood pressure is 150/90 mm Hg, hemoglobin A1C value is 8%, LDL cholesterol level is 90 mg/dL (2.33 mmol/L), and serum electrolyte values are within normal range. His current medications are glyburide 10 mg twice daily, simvastatin 40 mg daily, and hydrochlorothiazide 25 mg daily. The physician helps the patient set a specific health goal for the next few weeks (i.e., to walk his dog at least 10 minutes 5 days a week after lunch), adds lisinopril 10 mg daily and metformin 500 mg twice daily to the patient's treatment regimen, and provides counseling and information about these new medications.

Which of the following is the most important additional step for supporting this patient?

A. Ask the patient to schedule an appointment if his health status changes

B. Schedule a follow-up appointment in 1 month

C. Refer him to a community exercise program

D. Refer him to a diabetes educator

Click here for correct answer.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 02 December, 2011 and appeared in  Issue 602

Past five issues: Issue 766 | Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 |

2015 Most Popular Articles:

Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
New Guideline Released on Pharmacological Management of Obesity
Posted January 23, 2015
Dr. Timothy Garvey on Qsymia and Other New Therapies for Weight Loss
Posted January 12, 2015
For Your Patients: Practical Advice to Rev Up Your Workouts and Lower Fatigue
Posted January 09, 2015
Phentermine and Topirimate ER (Qsymia) Studied for Type 2 Diabetes Patients
Posted January 15, 2015
Handbook of Diabetes, 4th Ed., Excerpt #25: Specific Circumstances that Affect Diabetes Control
Posted January 04, 2015
New Insulin Glargine 300 Effective in Type 1 Diabetes
Posted January 16, 2015
FDA Approves Maestro Electronic Weight Loss Device
Posted January 23, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Will you prescribe inhaled insulin (Afrezza) when it becomes available this year?



Search Articles On Diabetes In Control